doi.org/10.1002/hep.31089

Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma

,

,

..., Jessica Dyson

Hepatology15.80

Volume: 71, Issue: 6, Pages: 2164 - 2166

Published: Dec 24, 2019

Paper Fields

Paper Details

Title

Pembrolizumab as a Cause of Cholangiopathy in a Patient With Metastatic Melanoma

DOI

doi.org/10.1002/hep.31089

Published Date

Dec 24, 2019

Journal

Volume

71

Issue

6

Pages

2164 - 2166

Notes

History